Tres Alchemix Co. Ltd. Raises $4.4M In Series A Funding to Accelerate AI-Driven Drug Discovery
Funds will support R&D expansion in Oxford, UK, and the design of novel drugs through direct prediction of therapeutic and potential adverse effects
President Tanaka of Waseda University Meets with Tres Alchemix Ltd.
Paving the path for future collaboration.
Tres Alchemix Co.Ltd. Raises 200 Million Yen in Funding
Seed Round Provides Capital for Development of AI Platform.